Your current location:HOME >entertainment >Why Amylyx is pulling ALS drug Relyvrio from US market after study 正文
TIME:2024-04-30 03:22:09 Source: Internet compilationEdit:entertainment
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
Chinese foreign ministry official on US Secretary of State Blinken's visit to China2024-04-30 03:08
Pacers hit franchise playoff best 22 32024-04-30 02:49
Seasonal 'rocket chasers' ignite aerospace tourism boom in China2024-04-30 02:43
Top French diplomat arrives in Lebanon in attempt to broker a halt to Hezbollah2024-04-30 02:42
3 dead, 4 missing in explosion at Italy power station2024-04-30 02:22
A Chinese storm chaser2024-04-30 02:16
Chinese premier holds symposium with overseas buyers at Canton Fair2024-04-30 02:03
iQIYI signs strategic partnership with Tourism Authority of Thailand2024-04-30 01:40
Chinese FM holds talks with Bolivian counterpart2024-04-30 01:18
Spring Festival travel rush sees 34.74 mln trips on first day2024-04-30 01:14
Chinese enterprises keen to expand int'l market: Trade council2024-04-30 03:19
Pacers hit franchise playoff best 22 32024-04-30 03:10
China's Einstein Probe astronomical satellite captures its first in2024-04-30 02:33
Struggling Granada sack coach Medina2024-04-30 02:28
At least 15 killed in Israeli airstrikes on Rafah2024-04-30 02:21
Festive holiday bodes well for tourism rebound2024-04-30 01:42
Horses show off in Versailles, keeping alive royal tradition on soon2024-04-30 01:30
Massive flooding hits China's Guangdong2024-04-30 01:08
FDA brings lab tests under federal oversight in bid to improve accuracy and safety2024-04-30 01:00
Yangtze town has a foot in the past and an eye on the future2024-04-30 00:51